Literature DB >> 27484855

High frequency of vertebral fracture and low bone quality in patients with rheumatoid arthritis-Results from TOMORROW study.

Tadashi Okano1, Kentaro Inui1, Masahiro Tada2, Yuko Sugioka3, Kenji Mamoto1, Shigeyuki Wakitani4, Tatsuya Koike3,5, Hiroaki Nakamura1.   

Abstract

OBJECTIVES: Osteoporosis is one of the complications in patients with rheumatoid arthritis (RA). In this study, we researched the morbidity of existing vertebral fractures and the risk factors for vertebral fractures in patients with RA.
METHODS: This study included 413 participants, 208 patients with RA, and 205 age- and sex-matched controls without RA. Clinical data, radiographic assessment of vertebral fracture from T4 to L4 in thoracic and lumber spine, bone mineral density (BMD), and bone metabolic markers (BMM) were analyzed.
RESULTS: Vertebral fractures were observed more frequently, severe and multiple in patients with RA. In the logistic regression analysis, age (adjusted odds ratios (OR): 1.07, 95% confidence interval (CI): 1.04-1.09) and RA (adjusted OR: 1.72, 95% CI: 1.04-2.83) were risk factors for existing vertebral fracture. Moreover, two bone matrix-related markers, undercarboxylated osteocalcin (ucOC) (adjusted OR: 1.68, 95% CI: 1.02-2.78), and urinary pentocidine (adjusted OR: 2.51, 95% CI: 1.48-4.24) were associated with existing vertebral fracture.
CONCLUSIONS: High frequent, multiple, and severe vertebral fractures were found in patients with RA compared to the controls. Low bone quality might be the cause of the frequent prevalence of vertebral fracture in patients with RA.

Entities:  

Keywords:  Bone mineral density; Bone quality; Osteoporosis; Rheumatoid arthritis; Vertebral fracture

Mesh:

Year:  2016        PMID: 27484855     DOI: 10.1080/14397595.2016.1213943

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  10 in total

Review 1.  Skeletal complications of rheumatoid arthritis.

Authors:  L Heinlen; M B Humphrey
Journal:  Osteoporos Int       Date:  2017-08-04       Impact factor: 4.507

2.  Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis.

Authors:  Yang Liu; Jun Jiang; Minmin Mo; Xiaohong Sun; Kailong Yu
Journal:  Clin Rheumatol       Date:  2022-01-10       Impact factor: 2.980

3.  Surgical Management of the Lumbar Spine in Rheumatoid Arthritis.

Authors:  Peter Joo; Laurence Ge; Addisu Mesfin
Journal:  Global Spine J       Date:  2019-11-06

4.  Prednisone prevents particle induced bone loss in the calvaria mouse model.

Authors:  Michael M Schündeln; Jakob Höppner; Felix L Meyer; Wiebke Schmuck; Max D Kauther; Gero Hilken; Bodo Levkau; Martina Rauner; Corinna Grasemann
Journal:  Heliyon       Date:  2021-08-18

5.  Increased risk of vertebral fracture in patients with rheumatoid arthritis: A meta-analysis.

Authors:  Bin Chen; Guangqi Cheng; Hantao Wang; Yu Feng
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Non-Hepatic Alkaline Phosphatase, hs-CRP and Progression of Vertebral Fracture in Patients with Rheumatoid Arthritis: A Population-Based Longitudinal Study.

Authors:  Jih-Chen Yeh; Chang-Chin Wu; Cheuk-Sing Choy; Shu-Wei Chang; Jian-Chiun Liou; Kuo-Shu Chen; Tao-Hsin Tung; Wei-Ning Lin; Chih-Yu Hsieh; Chun-Ta Ho; Ting-Ming Wang; Jia-Feng Chang
Journal:  J Clin Med       Date:  2018-11-13       Impact factor: 4.241

7.  Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables.

Authors:  Laura Niccoli; Carlotta Nannini; Corrado Blandizzi; Stefania Mantarro; Marta Mosca; Ombretta Di Munno; Delia Goletti; Maurizio Benucci; Francesca Li Gobbi; Emanuele Cassarà; Olga Kaloudi; Fabrizio Cantini
Journal:  Ther Clin Risk Manag       Date:  2018-10-24       Impact factor: 2.423

8.  Osteosarcopenia synergistically increases the risk of falls in patients with rheumatoid arthritis.

Authors:  Masahiro Tada; Yutaro Yamada; Koji Mandai; Yoshinari Matsumoto; Noriaki Hidaka
Journal:  Osteoporos Sarcopenia       Date:  2021-12-04

9.  Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease.

Authors:  Edgar Wiebe; Dörte Huscher; Désireé Schaumburg; Andriko Palmowski; Sandra Hermann; Thomas Buttgereit; Robert Biesen; Gerd-Rüdiger Burmester; Yannick Palmowski; Maarten Boers; John H Stone; Christian Dejaco; Frank Buttgereit
Journal:  Ann Rheum Dis       Date:  2022-06-09       Impact factor: 27.973

10.  Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses.

Authors:  Helena Florez; Jose Hernández-Rodríguez; Josep Lluis Carrasco; Sergio Prieto-González; Africa Muxi; Xavier Filella; Silvia Ruiz-Gaspà; José A Gómez-Puerta; Maria Cid; Gerard Espinosa; Ana Monegal; Núria Guañabens; Pilar Peris
Journal:  RMD Open       Date:  2020-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.